AstraZeneca announced its decision of further investing $90 million over the next 5 years in India. This investment commitment will span across AstraZeneca's diverse footprint in India with an aim to strengthen its manufacturing, clinical operations, patient safety & regulatory science, IT services and commercial operations. Furthermore this investment will support scientific data generation, quality manufacturing, science talent development and collaborative development of innovative solutions to improve the standard of care of non-communicable diseases in India. The commitment also aligns closely with the Indian government's initiatives to create a stronger business, innovation, and healthcare environment such as "Skill India", "National Health Policy" and Ayushman Bharat. The company recently announced expansion of its Global Technology Centre (GTC) in Chennai, now employing more than 2,000 employees.